De Wildeman Stefaan M A, Sonke Theo, Schoemaker Hans E, May Oliver
DSM Pharmaceuticals Products, Advanced Synthesis, Catalysis and Development, PO Box 18, 6160 MD Geleen, The Netherlands.
Acc Chem Res. 2007 Dec;40(12):1260-6. doi: 10.1021/ar7001073. Epub 2007 Oct 18.
Enzyme-catalyzed reductions have been studied for decades and have been introduced in more than 10 industrial processes for production of various chiral alcohols, alpha-hydroxy acids and alpha-amino acids. The earlier hurdle of expensive cofactors was taken by the development of highly efficient cofactor regeneration methods. In addition, the accessible number of suitable dehydrogenases and therefore the versatility of this technology is constantly increasing and currently expanding beyond asymmetric production of alcohols and amino acids. Access to a large set of enzymes for highly selective C=C reductions and reductive amination of ketones for production of chiral secondary amines and the development of improved D-selective amino acid dehydrogenases will fuel the next wave of industrial bioreduction processes.
酶催化还原反应已被研究了数十年,并已被应用于10多种工业生产过程中,用于生产各种手性醇、α-羟基酸和α-氨基酸。早期昂贵辅酶这一障碍已通过高效辅酶再生方法的开发得以克服。此外,合适的脱氢酶数量不断增加,因此这项技术的通用性也在不断提高,目前其应用范围已超出了醇类和氨基酸的不对称生产。获得大量用于高度选择性C=C还原以及酮的还原胺化反应以生产手性仲胺的酶,以及开发改进的D-选择性氨基酸脱氢酶,将推动下一波工业生物还原过程的发展。